ALLENTOWN, Pa. — Lehigh Valley biopharma facility is expanding.
US Specialty Formulations (USSF), a leading provider of high-quality pharmaceutical solutions for healthcare, diagnostics and new drug developers, is set to expand its Lehigh Valley facility.
The multi-phase project is a $15M initiative, USSF says in a press release.
$4.7M is already secured, USSF reports.
The expansion will include clean room suites and state-of-the-art automated packaging and product inspection equipment.
This expansion will increase USSF’s clean room production capacity by more than 2.5 times, officials say.
The expansion is expected to be completed at the end of 2025.
USSF hopes to employ more than 100 people to support the Allentown facility.
